Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Henri,Sova

第一单位： a Department of Obstetrics and Gynaecology , University of Oulu and Oulu University Hospital, Medical Research Centre, PEDEGO Research Unit , Oulu , Finland.

作者： Henri,Sova ^[1] ; Leila,Unkila-Kallio ^[2] ; Aila,Tiitinen ^[2] ; Maritta,Hippeläinen ^[3] ; Antti,Perheentupa ^[4] ; Helena,Tinkanen ^[5] ; Katri,Puukka ^[6] ; Risto,Bloigu ^[7] ; Terhi,Piltonen ^[8] ; Juha S,Tapanainen ^[1] ; Laure,Morin-Papunen ^[1]

作者单位： a Department of Obstetrics and Gynaecology , University of Oulu and Oulu University Hospital, Medical Research Centre, PEDEGO Research Unit , Oulu , Finland. ^[1] b Department of Obstetrics and Gynaecology , University of Helsinki and Helsinki University Hospital , Helsinki , Finland. ^[2] c Department of Obstetrics and Gynaecology , Kuopio University Hospital , Kuopio , Finland. ^[3] d Department of Obstetrics and Gynaecology , Turku University Hospital , Turku , Finland. ^[4] e Department of Obstetrics and Gynaecology , Tampere University Hospital , Tampere , Finland. ^[5] f Department of Clinical Chemistry , Oulu University Hospital , Oulu , Finland. ^[6] g NordLab Oulu , Oulu University Hospital , Oulu , Finland. ^[7] h Medical Informatics and Statistics Research Group, University of Oulu , Oulu , Finland. ^[8]

关键词 Polycystic ovary syndrome anti-Müllerian hormone hyperandrogenism metabolic risks phenotype of PCOS